NCT02412852View on ClinicalTrials.gov

A Phase 2a Study to Assess Safety & Pharmacokinetics of Sustained Release Sodium Nitrite in Patients With Diabetic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 28, 2015

Primary Completion Date

December 7, 2015

Study Completion Date

April 3, 2017

Conditions
Diabetes
Interventions
DRUG

Sodium nitrite

Sustained release formulation of sodium nitrite

DRUG

Placebo

Placebo tablets containing same excipients and coatings used in the active tablets, without sodium nitrite being added.

Trial Locations (1)

45458

Ohio Pain Clinic, Centerville

All Listed Sponsors
collaborator

Kettering Health Network

OTHER

lead

TheraVasc Inc.

INDUSTRY

NCT02412852 - A Phase 2a Study to Assess Safety & Pharmacokinetics of Sustained Release Sodium Nitrite in Patients With Diabetic Pain | Biotech Hunter | Biotech Hunter